awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37820433-AE0E42CB-B69A-4D11-A096-49096162032C
Q37820433-AE0E42CB-B69A-4D11-A096-49096162032C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37820433-AE0E42CB-B69A-4D11-A096-49096162032C
What is the best frontline therapy for patients with CLL and 17p deletion?
P2860
Q37820433-AE0E42CB-B69A-4D11-A096-49096162032C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37820433-AE0E42CB-B69A-4D11-A096-49096162032C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ffb3f81816ad77183c986913502afec673891e1
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.